Acetyl Tyrosine
CAS 537-55-3
Acetyl Tyrosine (CAS 537-55-3) is a pharmaceutical compound with 2 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 11019.6 nM | 2 | - |
| - | IC50 | 19976.309999999998 nM | 1 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| ACETYL L-TYROSINE | 31005 | SU | MTHSPL |
| N-ACETYLTYROSINE | 31005 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Acetyl Tyrosine used for in pharmaceutical contexts?
Acetyl Tyrosine (CAS 537-55-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Acetyl Tyrosine?
No adverse-event association or SIDER side-effect rows are rendered for Acetyl Tyrosine in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Acetyl Tyrosine also used in cosmetics?
No same-CAS cosmetics profile is rendered from the ingredients-table cross-reference for Acetyl Tyrosine.
What clinical phase is Acetyl Tyrosine in?
No phase 1-4 clinical development badge is rendered for Acetyl Tyrosine because the matched compound identifier rows do not contain a max-phase value.